ENDOWED PHYSICIAN/PHYSICIAN-SCIENTIST LEADERSHIP POSITION IN THORACIC ONCOLOGY

Location
Albuquerque, New Mexico
Salary
Commensurate with experience & generous package of fringe benefits
Posted
May 26, 2017
Closes
Jul 26, 2017
Hours
Full Time

ENDOWED PHYSICIAN/PHYSICIAN-SCIENTIST LEADERSHIP POSITION IN THORACIC ONCOLOGY
CLINICAL AND TRANSLATIONAL RESEARCH

THE UNIVERSITY OF NEW MEXICO COMPREHENSIVE
CANCER CENTER

UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE

The University of New Mexico NCI-Designated Comprehensive Cancer Center (UNMCCC) and the Department of Internal Medicine, Division of Hematology/Oncology at the UNM School of Medicine invite applications from physician or physician scientists with expertise in clinical care and translational/clinical research in thoracic oncology to provide leadership of the UNMCCC Lung and Aerodigestive Cancer Clinical and Clinical/Translational Research Programs. Applications are invited from mid-career physicians or physician-scientists (M.D. or M.D, Ph.D.) who may be appointed at the Associate or Full Professor level. Faculty rank and appointment will be commensurate with accomplishments. Emphasis is placed on the ability to foster interactions between laboratory and clinical investigators, lead and participate in multidisciplinary clinical trial teams focused on development and conduct of therapeutic and non-therapeutic interventional clinical trials, including investigator-initiated and early-phase clinical trials, and participate in the teaching mission of the Division, Center, and institution. The successful applicant will have a sustained track record of academic accomplishments including peer-reviewed extramural funding (NIH, NCI, or equivalent), expertise in translational and clinical cancer research and/or clinical trials, high quality publications, and the ability to develop and lead highly collaborative trans-disciplinary research teams. Applicants whose research is highly synergistic with the existing NCI Research Programs of the UNMCCC, highlighted below, will be given priority. Significant resources, including Endowed Chairs and Professorships and comprehensive start-up packages are available. 

Minimum Qualifications Include: 1) MD or MD/PhD degree or equivalent with board certification in Internal Medicine; 2) Specialty Board Certification in Medical Oncology; 3) A track record of sustained academic accomplishments including peer-reviewed research funding, publications, and/or relevant clinical trials in thoracic oncology; and 4) Must be eligible to work in the U.S.; this is not a J-1 Visa opportunity. Preferred Qualifications include: 1) Leadership experience and experience building multidisciplinary research teams and developing multi-investigator grants and programs; 2) experience in thoracic cancer clinical trials, investigator initiated trials, and early phase clinical trials and interventions; and 3) experience in training and education.

The University of New Mexico Comprehensive Cancer Center is the Official Cancer Center of New Mexico and the only National Cancer Institute-designated Cancer Center in a 500-mile radius. Its 125 board-certified oncology specialty physicians include cancer surgeons in every specialty (abdominal, thoracic, bone and soft tissue, neurosurgery, genitourinary, gynecology, and head and neck cancers), adult and pediatric hematologists/medical oncologists, gynecologic oncologists, and radiation oncologists. They, along with more than 500 other cancer healthcare professionals (nurses, pharmacists, nutritionists, navigators, psychologists and social workers), provided cancer care for nearly 60 percent of the adults and children in New Mexico affected by cancer. They treated 11,249 patients in 84,875 ambulatory clinic visits in addition to in-patient hospitalizations at UNM Hospital. These patients came from every county in the State. More than 12 percent of these patients participated in cancer clinical trials testing new cancer treatments and 35 percent of patients participated in other clinical research studies, including tests of novel cancer prevention strategies and cancer genome sequencing. The 130 cancer research scientists affiliated with the UNMCCC were awarded almost $60 million in federal and private grants and contracts for cancer research projects and published 301 high quality publications. Promoting economic development, they filed more than 30 new patents in FY16, and since 2010, have launched 11 new biotechnology start-up companies. Scientists associated with the UNMCCC Cancer Control & Disparities have conducted more than 60 statewide community-based cancer education, prevention, screening, and behavioral intervention studies involving more than 10,000 New Mexicans. Finally, the physicians, scientists and staff have provided education and training experiences to more than 230 high school, undergraduate, graduate, and postdoctoral fellowship students in cancer research and cancer health care delivery. Learn more at http://cancer.unm.edu/

To apply and view the complete description, please access Req986 at:   https://unm.csod.com/ats/careersite/search.aspx?site=1&c=unm

Complete applications will include a cover letter, curriculum vitae, and the names of three references with mailing address, phone numbers and email address.  

For all inquiries or questions, please contact: Search Chair: Dr. Olivier Rixe, MD, PhD, UNMCC Associate Director for Clinical Research at: orixe@unm.edu or (505) 925-0479, or, Search Coordinator: Denise Osborne at: dosborne@salud.unm.edu
or (505) 925-0415
.

This position may be subject to criminal records screening in accordance with New Mexico law.  UNM’s confidential policy (Disclosure of Information about Candidates for Employment, UNM Board of Regents Policy Manual 6.7), which includes information about public disclosure of documents submitted by applicants, is located at http://policy.unm.edu/regents-policies/section-6/6-7.html

The University of New Mexico is an Equal Employment Opportunity/Affirmative Action Employer